Bolivar Medical Center offers innovative new treatment for blood clots

Early clot treatment for leg veins said to improve patient outcomes

Cleveland, MS • June 8, 2010 Bolivar Medical Center is taking the fight to Deep Vein Thrombosis (DVT). Major healthcare organizations released guidance in 2008 calling for a more aggressive approach to
the management of DVT. Bolivar Medical Center is proud to be on the leading edge of the DVT Revolution.

In 2008 three major organizations tasked with providing clinical practices for the care
of patients released guidance supporting a more aggressive approach to early removal of DVT.
The National Quality Forum/Joint Commission released consensus standards regarding the prevention and treatment of DVT which require hospitals to have a plan in place to manage this patient population.

The American College of Chest Physicians published evidence-based clinical practice guidelines for DVT calling for pharmacomechanical thrombolysis in certain types of DVT.

The Office of the Surgeon General issued only its 7th Urgent Call to Action in eleven years focusing on the need to take a proactive approach in the prevention, diagnosis and treatment of DVT.

Deep Vein Thrombosis occurs when a clot forms in the deep veins of the leg or arm. It happens to over 600,000 people each year. Left untreated, it can lead to a potentially life-threatening condition called Pulmonary Embolism (PE) or a long-term life limiting condition called Post-thrombotic Syndrome (PTS).

PTS can occur in as little as one month and is a direct result of injury to the vein due to the long-term presence of clot.

Historically DVT has been treated with blood thinners known as anticoagulation therapy. Anticoagulation alone will help prevent the clot from propagating and can protect against PE. Anticoagulation does not remove the clot, rather it relies on the body's own internal mechanisms which may take as long as several months.

Bolivar Medical Center offers isolated pharmacomechanical treatment with the Trellis® Peripheral Infusion System, an FDA cleared device from Covidien of Mansfield, MA, to increase the efficiency of thrombolytic or "clot busting" drugs in mixing with and removing blood clots. The system is also designed to reduce the risk of bleeding complications that are often associated with the use of thrombolytic drugs. Instead of potentially waiting months to clear up, a DVT can be removed within two hours in most cases.

Dr. Suresh Vedantham, lead investigator for the NIH-funded ATTRACT Trial recently published an article on thrombolysis in the American Journal of Medicine which stated "...use of isolated thrombolysis was associated with successful DVT lysis in 96% of patients..." and "...therapy can be completed in a single procedure session in most patients."

Leading the effort at Bolivar Medical Center is Patrick Sewell, MD an Interventional Radiologist in the Bolivar Medical Center's Radiology Department. Dr. Sewell noted that "This is the first major change in the way we treat this illness in 50 years.  It is a significant advance that increases patient safety and shortens treatment time and hospitalization time from several days to one day in most cases."

"This procedure has significantly decreased the long term consequences of a DVT and shortened the time for in-patient treatment for my patients receiving this therapy," states Dr. Steven Clark, Internal Medicine physician of Cleveland.

Commenting for Bolivar Medical Center, Wes Sigler, CEO stated that "Our goal is to continue to grow and provide the most sophisticated care for our patients.  We are privileged to offer this procedure in our community, matching the care of larger metropolitan areas such as Memphis or Jackson."

For additional information on this new technique, please contact Lauren Walker, Director of Marketing, at Bolivar Medical Center. Trellis is a registered trademark of Covidien.